VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+21.8%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
(+26%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
14.61%
Top 10 Holdings %
Top 10 Hldgs %
86.64%
Holding
50
New
32
Increased
4
Reduced
2
Closed
4
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$6.7M |
| 2 |
Protara Therapeutics
TARA
|
$5.31M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$2.32M |
| 4 |
Replimune Group
REPL
|
$2.2M |
| 5 |
Tourmaline Bio
TRML
|
$1.88M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$3.9M |
| 2 |
scPharmaceuticals
SCPH
|
$2.36M |
| 3 |
TELA Bio
TELA
|
$1.89M |
| 4 |
OPTN
OptiNose
OPTN
|
$1.44M |
| 5 |
Context Therapeutics
CNTX
|
$1.26M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Jasper Therapeutics
JSPR
$45.5M
| $30.7M | 26.45% | 1,433,828 | – | – |
|
|
2
Praxis Precision Medicines
PRAX
$958M
| $23.1M | 19.92% | 300,000 -50,666 | -14% | -$3.9M |
|
3
Heron Therapeutics
HRTX
$207M
| $10.7M | 9.22% | 6,986,744 | – | – |
|
|
4
Tourmaline Bio
TRML
$601M
| $8.59M | 7.42% | 423,795 +92,605 | +28% | +$1.88M |
|
|
5
Protara Therapeutics
TARA
$120M
| $8.34M | 7.19% | 1,579,000 +1,005,000 | +175% | +$5.31M |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $6.7M | 5.78% | +185,520 | New | +$6.7M |
|
7
Rezolute
RZLT
$619M
| $3.92M | 3.38% | 800,000 | – | – |
|
8
Liquidia Corp
LQDA
$2.38B
| $3.53M | 3.04% | 300,000 | – | – |
|
9
Zevra Therapeutics
ZVRA
$509M
| $2.5M | 2.16% | 300,000 +100,000 | +50% | +$834K |
|
10
InspireMD
NSPR
$102M
| $2.38M | 2.05% | 904,029 | – | – |
|
|
VRNA
11
Verona Pharma
VRNA
$9.16B
| $2.32M | 2% | +50,000 | New | +$2.32M |
|
|
12
Replimune Group
REPL
$422M
| $2.2M | 1.9% | +181,367 | New | +$2.2M |
|
13
Nurix Therapeutics
NRIX
$714M
| $1.84M | 1.59% | +97,889 | New | +$1.84M |
|
14
Perspective Therapeutics
CATX
$250M
| $1.6M | 1.38% | +500,000 | New | +$1.6M |
|
15
Eledon Pharmaceuticals
ELDN
$155M
| $1.33M | 1.15% | +323,973 | New | +$1.33M |
|
16
Kura Oncology
KURA
$686M
| $1.31M | 1.13% | +150,000 | New | +$1.31M |
|
17
Collegium Pharmaceutical
COLL
$1.22B
| $822K | 0.71% | +28,685 | New | +$822K |
|
18
Avalo Therapeutics
AVTX
$122M
| $817K | 0.71% | +109,972 | New | +$817K |
|
19
Corbus Pharmaceuticals
CRBP
$115M
| $669K | 0.58% | 56,700 +6,700 | +13% | +$79.1K |
|
20
Tenax Therapeutics
TENX
$27.3M
| $516K | 0.45% | 83,333 | – | – |
|
21
Kiora Pharmaceuticals
KPRX
$9.55M
| $403K | 0.35% | 122,223 | – | – |
|
22
Geron
GERN
$893M
| $173K | 0.15% | +49,000 | New | +$173K |
|
23
Wave Life Sciences
WVE
$1.53B
| $161K | 0.14% | +13,000 | New | +$161K |
|
|
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
| $111K | 0.1% | +70,000 | New | +$111K |
|
25
ProQR Therapeutics
PRQR
$237M
| $107K | 0.09% | +40,500 | New | +$107K |
|